LACTULOSE - A DRUG WITH ANTI-ENDOTOXIN EFFECT

Abstract

Lactulose (.beta.-galactosido-fructose) has anti-endotoxin properties: 670 mg lactulose abolished the gelating activity of 1 mg Escherichia coli endotoxin on Limulus lysate in vitro. When lactulose was fed to rats (6.3 .+-. 1.1 g/kg per day) over a period of 4 or 8 days before i.v. administration of 0.5 g/kg galactosamine, the liver damage that normally develops was prevented. Since galactosamine-induced necrosis of hepatocytes and inflammatory reaction of the liver are mediated by systemic endotoxemia of intestinal origin, an anti-endotoxin effect of lactulose was demonstrated in vivo. Lactulose might offer a therapeutic basis in clinical situations in which endotoxemia is of pathogenetic significance, e.g., certain gastrointestinal and liver diseases, shock states and gram-negative sepsis.